If you Believe that the in situ system will work at just 50% predicted with copper at 4 this company will have a $150 million yearly profit in 2 years.
Marty Sullivan
Posts (4)
I am a physician and researcher. D is much larger than hae drug. Bullish to $50
This company is already profitable with a pe of 12. It also has a giant untapped reserve. It should fly.
If the oral ATB is approved it will generate $300-400 million per year. I am a physician. It will be used a lot. Market cap should go to 7 times earnings. 2 billion. With dilution stock is $14-20 per share